Literature DB >> 3652513

Variation of serum and intestinal gluten antibody specificities in coeliac disease.

J H Skerritt1, R B Johnson, P A Hetzel, J T La Brooy, D J Shearman, G P Davidson.   

Abstract

Protein blotting techniques were used to investigate the gluten specificity of IgA and IgG antibodies in sera and intestinal aspirates from patients with coeliac disease and normal controls. Initially, discontinuous SDS polyacrylamide gel electrophoresis was used to separate the flour proteins. All normal and coeliac sera contained antibodies which bound to various of the gliadin proteins. In only a few sera was binding found to the high molecular weight glutenin subunits, while none was detected to the salt-soluble wheat proteins. Polyacrylamide gradient gel electrophoresis was then used to further separate the gliadin proteins. Almost all normal sera examined showed similar gliadin specificity, binding uniformly to all gliadin groups. While approximately a quarter of the coeliac sera showed even binding to all of the gliadin proteins, the majority showed antibody binding intensely to discrete groups of gliadin bands. We were unable to identify any gliadin band(s) which only bound antibodies from coeliac patients in comparison with normal subjects. The specificities of IgG and IgA serum antibodies were identical for each patient examined, but some differences between serum and intestinal IgA specificities were found for certain patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3652513      PMCID: PMC1542689     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Immunofluorescent serum gliadin antibodies in children with coeliac disease and various malabsorptive disorders. II. Specificity of Gliadin antibodies: immunoglobulin classes, immunogenic properties of wheat protein fractions, and pathogenic significance of food antibodies in coeliac disease.

Authors:  M Stern; K Fischer; R Grüttner
Journal:  Eur J Pediatr       Date:  1979-03-01       Impact factor: 3.183

2.  Gluten subfractions in coeliac disease.

Authors:  M J Kendall; R Schneider; P S Cox; C F Hawkins
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

3.  Plasma food antibodies during withdrawal and reintroduction of dietary gluten in coeliac disease.

Authors:  F Carswell; A Ferguson
Journal:  Arch Dis Child       Date:  1973-08       Impact factor: 3.791

4.  Protein mapping by combined gel electrofocusing and electrophoresis: application to the study of genotypic variations in wheat gliadins.

Authors:  C W Wrigley
Journal:  Biochem Genet       Date:  1970-08       Impact factor: 1.890

5.  IgA anti-gliadin antibodies in coeliac disease.

Authors:  D J Unsworth; M Kieffer; E J Holborow; R R Coombs; J A Walker-Smith
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

7.  The antibody response to bacterial gastroenteritis in serum and secretions.

Authors:  J T La Brooy; G P Davidson; D J Sherman; D Rowley
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

8.  Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children.

Authors:  A Ferguson; F Carswell
Journal:  Br Med J       Date:  1972-01-08

9.  The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN).

Authors:  A S McNeish; H K Harms; J Rey; D H Shmerling; J K Visakorpi; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1979-10       Impact factor: 3.791

10.  Clinical testing of bread made from nullisomic 6A wheats in coeliac patients.

Authors:  P J Ciclitira; J O Hunter; E S Lennox
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

View more
  5 in total

1.  The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum.

Authors:  W W Stewart; M A Kerr
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

2.  Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.

Authors:  J M Devery; J T La Brooy; S Krillis; G Davidson; J H Skerritt
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

3.  Antibody response reveal differences in oral tolerance to wheat and maize grain protein fractions.

Authors:  R B Johnson; J T Labrooy; J H Skerritt
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  Dissociation between systemic and mucosal humoral immune responses in coeliac disease.

Authors:  S O'Mahony; E Arranz; J R Barton; A Ferguson
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

5.  Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.

Authors:  Tamara Matysiak-Budnik; Ivan Cruz Moura; Michelle Arcos-Fajardo; Corinne Lebreton; Sandrine Ménard; Céline Candalh; Karima Ben-Khalifa; Christophe Dugave; Houda Tamouza; Guillaume van Niel; Yoram Bouhnik; Dominique Lamarque; Stanislas Chaussade; Georgia Malamut; Christophe Cellier; Nadine Cerf-Bensussan; Renato C Monteiro; Martine Heyman
Journal:  J Exp Med       Date:  2007-12-31       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.